Skip to main content

CVS announces plan to eliminate co-pays for diabetes drugs

By The Motley Fool  
   January 29, 2020

According to a study by CVS Health's pharmacy benefit manager, CVS Caremark, the average diabetic spends $467.24 out-of-pocket per year on their medication, including insulin, and 12% of them lay out upwards of $1,000. As a result of those costs, some diabetes patients must sometimes forgo their medication, which can result in disease progression, and in some, lead to the development of heart disease.

Full story

Get the latest on healthcare leadership in your inbox.